Biogen Idec Offers Growth Investors An Attractive Entry Point
- Biogen Idec reported strong second quarter earnings on July 23rd.
- Biogen Idec increased its full year 2014 forward guidance.
- Following the strong second quarter results, analysts have revised their estimates higher for both this fiscal year 2014 and next fiscal year 2015.
- While shares of Biogen Idec have risen more than 8% following the second quarter report, the valuation still looks favorable.